These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28751829)

  • 1. Relationship between serum angiopoietin-like protein 2 and plaque vulnerability in patients with coronary artery disease and diabetes.
    Xie Z; Liu X; Tian J; Yin L; Yu B
    Eur Heart J Suppl; 2016 May; 18(Suppl F):F35-F36. PubMed ID: 28751829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum adipsin and plaque vulnerability determined by optical coherence tomography in patients with coronary artery disease.
    Sun R; Qiao Y; Yan G; Wang D; Zuo W; Ji Z; Zhang X; Yao Y; Ma G; Tang C
    J Thorac Dis; 2021 Apr; 13(4):2414-2425. PubMed ID: 34012589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes.
    Jung CH; Lee WJ; Lee MJ; Kang YM; Jang JE; Leem J; La Lee Y; Seol SM; Yoon HK; Park JY
    Cardiovasc Diabetol; 2015 Apr; 14():35. PubMed ID: 25889082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Serum Angiopoietin-like Protein 2 in Patients with Acute Coronary Syndrome.
    Wang Z; Zheng H; Chen H; Lin X; Chen J; Wang L; Bao W; Lin X; Huang M; Luo Z
    Arch Med Res; 2015 May; 46(4):257-64. PubMed ID: 25999029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Platelet to lymphocyte ratio with non-culprit atherosclerotic plaque vulnerability in patients with acute coronary syndrome: an optical coherence tomography study.
    Wang X; Xie Z; Liu X; Huang X; Lin J; Huang D; Yu B; Hou J
    BMC Cardiovasc Disord; 2017 Jul; 17(1):175. PubMed ID: 28673240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of epicardial fat volume on coronary plaque vulnerability: insight from optical coherence tomography analysis.
    Ito T; Nasu K; Terashima M; Ehara M; Kinoshita Y; Ito T; Kimura M; Tanaka N; Habara M; Tsuchikane E; Suzuki T
    Eur Heart J Cardiovasc Imaging; 2012 May; 13(5):408-15. PubMed ID: 22294682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of circulating levels of neopterin with non-culprit plaque vulnerability in CAD patients an angiogram, optical coherent tomography and intravascular ultrasound study.
    Sun Y; He J; Tian J; Xie Z; Wang C; Yu B
    Atherosclerosis; 2015 Jul; 241(1):138-42. PubMed ID: 25982822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
    Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
    Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Pentraxin3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease.
    Tazaki R; Tanigawa J; Fujisaka T; Shibata K; Takeda Y; Ishihara T; Hoshiga M; Hanafusa T; Ishizaka N
    Int Heart J; 2016; 57(1):18-24. PubMed ID: 26673442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study.
    Tian J; Ren X; Vergallo R; Xing L; Yu H; Jia H; Soeda T; McNulty I; Hu S; Lee H; Yu B; Jang IK
    J Am Coll Cardiol; 2014 Jun; 63(21):2209-16. PubMed ID: 24632266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Osue T; Kinutani H; Konishi A; Takahashi H; Terashita D; Uzu K; Hirata K
    Cardiovasc Diabetol; 2015 Jun; 14():78. PubMed ID: 26062762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of fibrous cap thickness by optical coherence tomography for positive remodeling and low-attenuation plaques assessed by computed tomography angiography.
    Sato A; Hoshi T; Kakefuda Y; Hiraya D; Watabe H; Kawabe M; Akiyama D; Koike A; Aonuma K
    Int J Cardiol; 2015 Mar; 182():419-25. PubMed ID: 25596470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Variability on Continuous Glucose Monitoring System Correlates With Non-Culprit Vessel Coronary Plaque Vulnerability in Patients With First-Episode Acute Coronary Syndrome - Optical Coherence Tomography Study.
    Gohbara M; Hibi K; Mitsuhashi T; Maejima N; Iwahashi N; Kataoka S; Akiyama E; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    Circ J; 2016; 80(1):202-10. PubMed ID: 26511357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of culprit and remote coronary narrowings using optical coherence tomography with long-term outcomes.
    Barlis P; Serruys PW; Gonzalo N; van der Giessen WJ; de Jaegere PJ; Regar E
    Am J Cardiol; 2008 Aug; 102(4):391-5. PubMed ID: 18678293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of optical coherence tomography and intravascular ultrasound for evaluation of coronary lipid-rich atherosclerotic plaque progression and regression.
    Xie Z; Tian J; Ma L; Du H; Dong N; Hou J; He J; Dai J; Liu X; Pan H; Liu Y; Yu B
    Eur Heart J Cardiovasc Imaging; 2015 Dec; 16(12):1374-80. PubMed ID: 25911116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
    Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
    Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart Failure.
    Huang CL; Wu YW; Wu CC; Hwang JJ; Yang WS
    PLoS One; 2015; 10(9):e0138678. PubMed ID: 26397985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma inflammatory markers and plaque fibrous cap thickness determined by intravascular optical coherence tomography.
    Li QX; Fu QQ; Shi SW; Wang YF; Xie JJ; Yu X; Cheng X; Liao YH
    Heart; 2010 Feb; 96(3):196-201. PubMed ID: 19875365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.